Claraphi Advisory Network’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Claraphi Advisory Network's VRTX Position: Q4 2022 in Review
Claraphi Advisory Network sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 771 shares — an estimated $223K sold.
Claraphi Advisory Network first reported a position in VRTX in Q1 2020 and held it in 3 quarters. The position peaked at $526K in Q2 2022. 1,222 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.
- Claraphi Advisory Network reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Claraphi Advisory Network sold 771 Vertex Pharmaceuticals shares in Q4 2022, an estimated $223K.
- Claraphi Advisory Network first reported a position in Vertex Pharmaceuticals in Q1 2020 and held it in 3 quarters.
- Claraphi Advisory Network's Vertex Pharmaceuticals position peaked at $526K in Q2 2022.
- 1,222 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.
Based on Claraphi Advisory Network's 13F filing for Q4 2022, filed 14 Feb 2023.